Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy. [electronic resource]
Producer: 20180827Description: 209-218 p. digitalISSN:- 1179-1985
- Aged
- Antineoplastic Agents -- adverse effects
- Asymptomatic Diseases
- Bortezomib -- adverse effects
- Cardiotoxicity
- Case-Control Studies
- Echocardiography, Doppler
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- diagnosis
- Oligopeptides -- adverse effects
- Proteasome Endopeptidase Complex -- drug effects
- Proteasome Inhibitors -- adverse effects
- Risk Factors
- Treatment Outcome
- Ventricular Dysfunction, Left -- chemically induced
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.